Key Events This Week
3 Aug: Stock opens strong at Rs.623.30 (+1.92%)
4 Aug: New 52-week high at Rs.655.6
5 Aug: Intraday high of Rs.695.05 with 7.34% surge; Q1 FY27 results show 115% profit growth
6 Aug: New 52-week high at Rs.786.55; Mojo Grade upgraded to Buy
7 Aug: Quality grade upgraded; stock closes at Rs.759.60 (-0.31%)
3 August 2026: Steady Start with 1.92% Gain
Shilpa Medicare Ltd began the week on a positive note, closing at Rs.623.30, up 1.92% on the day. This outpaced the Sensex’s 0.82% gain, signalling early strength. Trading volume was moderate at 22,587 shares, setting the stage for the week’s momentum. The broader market was buoyed by positive sentiment, with the Sensex closing at 36,985.17.
4 August 2026: New 52-Week High at Rs.655.6
The stock surged 4.03% to Rs.648.40, hitting a new 52-week high of Rs.655.6 intraday. This represented a 5.18% increase on the day and outperformed the Pharmaceuticals & Biotechnology sector by 3.4%. The rally was supported by the stock trading above all key moving averages, signalling a strong bullish trend. Despite a slight Sensex decline of 0.14%, Shilpa Medicare’s relative strength was evident.
5 August 2026: Intraday High of Rs.695.05 and Strong Q1 Results
On 5 August, the stock exhibited exceptional strength, surging 11.25% to close at Rs.721.35, with an intraday peak of Rs.695.05 marking a 7.34% gain during the session. This day marked the fourth consecutive gain, accumulating an 11.33% return over the period. The stock outperformed its sector by over 7%, even as the Sensex closed marginally higher by 0.38%. The surge coincided with the release of outstanding Q1 FY27 results, where Shilpa Medicare reported a 115% profit surge, net sales of ₹465.78 crores, and record operating profits, signalling robust operational momentum.
Just made the cut! This Mid Cap from the Heavy Electrical Equipment sector entered our elite Top 1% list recently. Discover it before the crowd catches on!
- - Top-rated across platform
- - Strong price momentum
- - Near-term growth potential
6 August 2026: New 52-Week High at Rs.786.55 and Mojo Upgrade
Shilpa Medicare Ltd continued its impressive run, hitting a new 52-week high of Rs.786.55 intraday and closing at Rs.740.05, up 2.59%. The stock outperformed the Sensex’s 0.28% gain by a wide margin, delivering a 9.04% intraday increase. This marked the fifth consecutive day of gains, with a cumulative return of 26.79%. Technical indicators including MACD, Bollinger Bands, and KST oscillators remained bullish across weekly and monthly charts. The company’s Mojo Score improved to 61.0 with a Hold rating, reflecting enhanced financial and market metrics.
7 August 2026: Quality Grade Upgrade and Slight Pullback
On the final trading day of the week, Shilpa Medicare’s quality grade was upgraded from below average to average, accompanied by a Mojo Score of 75.0 and a Buy rating. The stock closed at Rs.759.60, down 0.31% from the previous close, after touching a day high near its 52-week peak. The upgrade reflected strong sales and EBIT growth, improved interest coverage, and manageable debt levels. Despite the minor pullback, the stock’s year-to-date gain of 130.40% and one-year return of 80.07% underscore its exceptional performance relative to the Sensex.
Want to dive deeper on Shilpa Medicare Ltd? There's a real-time research report diving right into the fundamentals, valuations, peer comparison, financials, technicals and much more!
- - Real-time research report
- - Complete fundamental analysis
- - Peer comparison included
Weekly Price Performance vs Sensex
| Date | Stock Price | Day Change | Sensex | Day Change |
|---|---|---|---|---|
| 2026-08-03 | Rs.623.30 | +1.92% | 36,985.17 | +0.82% |
| 2026-08-04 | Rs.648.40 | +4.03% | 36,933.47 | -0.14% |
| 2026-08-05 | Rs.721.35 | +11.25% | 37,074.66 | +0.38% |
| 2026-08-06 | Rs.740.05 | +2.59% | 37,177.57 | +0.28% |
| 2026-08-07 | Rs.759.60 | +2.64% | 37,099.57 | -0.21% |
Key Takeaways
Strong Price Momentum: Shilpa Medicare Ltd’s 24.21% weekly gain vastly outperformed the Sensex’s 1.13%, driven by multiple new 52-week highs and sustained buying interest.
Robust Quarterly Results: The company’s Q1 FY27 results showcased a 115% profit surge and record sales of ₹465.78 crores, underpinning investor confidence and validating the rally.
Technical Strength: The stock consistently traded above all major moving averages, with bullish MACD, Bollinger Bands, and KST indicators supporting the uptrend.
Valuation and Rating Upgrades: Despite a very expensive valuation, the Mojo Grade was upgraded from Hold to Buy, and the quality grade improved to average, reflecting better fundamentals and market positioning.
Sector Outperformance: The stock outpaced the Pharmaceuticals & Biotechnology sector and small-cap indices, highlighting its leadership within its peer group.
Moderate Pullback on Final Day: A slight 0.31% decline on 7 August followed the quality upgrade, suggesting some short-term profit-taking amid strong gains.
Volume and Volatility: Trading volumes surged notably on key days, especially 5 and 6 August, coinciding with price spikes and signalling active market participation.
Conclusion
Shilpa Medicare Ltd’s exceptional 24.21% weekly gain from 3 to 7 August 2026 reflects a confluence of strong financial results, technical momentum, and positive rating upgrades. The stock’s ability to repeatedly hit new 52-week highs amid a mixed broader market environment underscores its robust market positioning and investor appeal. While valuation remains very expensive, the company’s operational improvements and upgraded mojo and quality grades provide a solid foundation for its current strength. Investors should monitor upcoming earnings releases and sector developments closely, as sustaining this momentum will depend on continued execution and market conditions.
Get 33% Off on our 1 Year Plan - Limited Period Only! Start Today
